Miyazato Yusuke, Yamamoto Kei, Nakaya Yuichiro, Morioka Shinichiro, Takeuchi Junko S., Takamatsu Yuki, Maeda Kenji, Kimura Moto, Sugiura Wataru, Mitsuya Hiroaki, Yano Masao, Ohmagari Norio .  Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19(和訳中) .  Journal of Infection and Chemotherapy28 ( 7 ) 991 - 994   2022年7月

Terayama Y, Tomita N, Terada-Hirashima J, Uemura Y, Shimizu Y, Takeuchi JS, Takamatsu Y, Maeda K, Mikami A, Ujiie M, Sugiura W .  Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA). .  Life (Basel, Switzerland)12 ( 7 ) 966 - 966   2022年6月

Takamatsu Y, Omata K, Shimizu Y, Kinoshita-Iwamoto N, Terada M, Suzuki T, Morioka S, Uemura Y, Ohmagari N, Maeda K, Mitsuya H .  SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG response. .  bioRxiv : the preprint server for biology   2022年6月国際誌

Tomita N, Saito S, Terada-Hirashima J, Mikami A, Uemura Y, Kutsuna S, Nomoto H, Fujisawa K, Nagashima M, Terada M, Ashida S, Morioka S, Satake M, Hangaishi A, Togano T, Shiratori K, Takamatsu Y, Maeda K, Ohmagari N, Sugiura W, Mitsuya H .  A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT). .  Life (Basel, Switzerland)12 ( 6 )   2022年6月国際誌

Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Iwamoto N, Ujiie M, Kutsuna S, Morioka S, Ishizaka Y, Mitsuya H, Ohmagari N .  Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection. .  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases119   18 - 20   2022年6月国際誌

Amano M, Maeda K, Tsuchiya K, Shimada S, Mitsuya H .  Third-dose BNT162b2 vaccination elicits markedly high-level SARS-CoV-2-neutralizing antibodies in vaccinees who poorly responded to second dose in Japan. .  The Journal of infectious diseases   2022年5月国際誌

Uraki R, Kiso M, Iida S, Imai M, Takashita E, Kuroda M, Halfmann PJ, Loeber S, Maemura T, Yamayoshi S, Fujisaki S, Wang Z, Ito M, Ujie M, Iwatsuki-Horimoto K, Furusawa Y, Wright R, Chong Z, Ozono S, Yasuhara A, Ueki H, Sakai-Tagawa Y, Li R, Liu Y, Larson D, Koga M, Tsutsumi T, Adachi E, Saito M, Yamamoto S, Hagihara M, Mitamura K, Sato T, Hojo M, Hattori SI, Maeda K, Valdez R, IASO study team., Okuda M, Murakami J, Duong C, Godbole S, Douek DC, Maeda K, Watanabe S, Gordon A, Ohmagari N, Yotsuyanagi H, Diamond MS, Hasegawa H, Mitsuya H, Suzuki T, Kawaoka Y .  Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2. .  Nature607 ( 7917 ) 119 - 127   2022年5月国際誌

Kamegai K, Iwamoto N, Togano T, Maeda K, Takamatsu Y, Miyazato Y, Ishikane M, Mizokami M, Sugiyama M, Iida S, Miyamoto S, Suzuki T, Ohmagari N .  A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy. .  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases121   85 - 88   2022年4月国際誌

Takashita E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, Fujisaki S, Ito M, Iwatsuki-Horimoto K, Halfmann P, Watanabe S, Maeda K, Imai M, Mitsuya H, Ohmagari N, Takeda M, Hasegawa H, Kawaoka Y .  Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2. .  The New England journal of medicine386 ( 15 ) 1475 - 1477   2022年4月国際誌

Khor SS, Omae Y, Takeuchi JS, Fukunaga A, Yamamoto S, Tanaka A, Matsuda K, Kimura M, Maeda K, Ueda G, Mizoue T, Ujiie M, Mitsuya H, Ohmagari N, Sugiura W, Tokunaga K .  An Association Study of HLA with the Kinetics of SARS-CoV-2 Spike Specific IgG Antibody Responses to BNT162b2 mRNA Vaccine. .  Vaccines10 ( 4 )   2022年4月国際誌

Yamamoto S, Fukunaga A, Tanaka A, Takeuchi JS, Inoue Y, Kimura M, Maeda K, Ueda G, Mizoue T, Ujiie M, Sugiura W, Ohmagari N .  Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine. .  Vaccine40 ( 13 ) 1924 - 1927   2022年3月国際誌

Takashita E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, Fujisaki S, Ito M, Iwatsuki-Horimoto K, Chiba S, Halfmann P, Nagai H, Saito M, Adachi E, Sullivan D, Pekosz A, Watanabe S, Maeda K, Imai M, Yotsuyanagi H, Mitsuya H, Ohmagari N, Takeda M, Hasegawa H, Kawaoka Y .  Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant. .  The New England journal of medicine386 ( 10 ) 995 - 998   2022年3月国際誌

Beppu H, Ogawa T, Ishikane M, Kawanishi T, Fukuda T, Sato L, Matsunaga A, Maeda K, Katagiri D, Ishizaka Y, Mitsuya H, Ohmagari N, Yasui F, Kohara M, Kikuchi K, Wakai S .  A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection. .  CEN case reports   2022年3月

Kawaoka Y, Uraki R, Kiso M, Iida S, Imai M, Takashita E, Kuroda M, Halfmann P, Loeber S, Maemura T, Yamayoshi S, Fujisaki S, Wang Z, Ito M, Ujie M, Iwatsuki-Horimoto K, Furusawa Y, Wright R, Chong Z, Ozono S, Yasuhara A, Ueki H, Sakai Y, Li R, Liu Y, Larson D, Koga M, Tsutsumi T, Adachi E, Saito M, Yamamoto S, Matsubara S, Hagihara M, Mitamura K, Sato T, Hojo M, Hattori SI, Maeda K, Okuda M, Murakami J, Duong C, Godbole S, Douek D, Watanabe S, Ohmagari N, Yotsuyanagi H, Diamond M, Hasegawa H, Mitsuya H, Suzuki T .  Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2. .  Research square   2022年2月国際誌

Takamatsu Y, Imai M, Maeda K, Nakajima N, Higashi-Kuwata N, Iwatsuki-Horimoto K, Ito M, Kiso M, Maemura T, Takeda Y, Omata K, Suzuki T, Kawaoka Y, Mitsuya H .  Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters. .  Journal of virology96 ( 4 ) e0155121   2022年2月国際誌

Satoshi Kutsuna, Sho Saito, Yuki Takamatsu, Mari Terada, Tomiteru Togano, Noriko Kinoshita, Kenji Maeda, Akihiro Matsunaga, Masahiro Satake, Keiji Matsubayashi, Nelson Hirokazu Tsuno, Makiko Kojima, Madoka Kuramitsu, Kenta Tezuka, Emi Ikebe, Kazu Okuma, Isao Hamaguchi, Yumiko Shimanishi, Akira Hangaishi, Yukihito Ishizaka, Norio Ohmagari, Hiroaki Mitsuya .  Safety of convalescent plasma therapy for COVID-19 patients and analysis of viral kinetics: a single-center, open-label, single-arm, interventional study in Japan .  GHM Open   2022年

Yamamoto S, Maeda K, Matsuda K, Tanaka A, Horii K, Okudera K, Takeuchi JS, Mizoue T, Konishi M, Ozeki M, Sugiyama H, Aoyanagi N, Mitsuya H, Sugiura W, Ohmagari N .  Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study. .  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America75 ( 1 ) e683 - e691   2021年12月国際誌

Matsuda K, Islam S, Takada T, Tsuchiya K, Yang Tan BJ, Hattori SI, Katsuya H, Kitagawa K, Kim KS, Matsuo M, Sugata K, Delino NS, Gatanaga H, Yoshimura K, Matsushita S, Mitsuya H, Iwami S, Satou Y, Maeda K .  A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents <i>in vitro</i>. .  Cell reports methods1 ( 8 ) 100122   2021年12月

Matsuda K, Islam S, Takada T, Tsuchiya K, Yang BTJ, Shin-ichiro Hattori SI, Katsuya H, Kitagawa K, Kim KS, Matsuo M, Sugata K, Delino NS, Gatanaga H, Yoshimura K, Matsushita S, Mitsuya H, Iwami S, Satou Y, Maeda K .  A widely-distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents in vitro .  Cell Rep. Methods   2021年12月査読

Maeda K, Amano M, Uemura Y, Tsuchiya K, Matsushima T, Noda K, Shimizu Y, Fujiwara A, Takamatsu Y, Ichikawa Y, Nishimura H, Kinoshita M, Matsumoto S, Gatanaga H, Yoshimura K, Oka SI, Mikami A, Sugiura W, Sato T, Yoshida T, Shimada S, Mitsuya H .  Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals. .  Scientific reports11 ( 1 ) 22848 - 22848   2021年11月国際誌

Junko S Takeuchi, Ami Fukunaga, Shohei Yamamoto, Akihito Tanaka, Kouki Matsuda, Moto Kimura, Azusa Kamikawa, Yumiko Kito, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie, Hiroaki Mitsuya, Norio Ohmagari, Wataru Sugiura .  SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2 .      2021年11月

Nomoto Hidetoshi, Yamamoto Kei, Yamada Gen, Suzuki Michiyo, Kinoshita Noriko, Takasaki Jin, Moriya Ataru, Maeda Kenji, Kimura Motoi, Ohmagari Norio .  重症急性呼吸器症候群コロナウイルス2型に対する定量抗原検査の経時的評価　COVID-19患者の隔離緩和に貢献する可能性(Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients) .  Journal of Infection and Chemotherapy27 ( 11 ) 1669 - 1673   2021年11月

Nomoto H, Yamamoto K, Yamada G, Suzuki M, Kinoshita N, Takasaki J, Moriya A, Maeda K, Kimura M, Ohmagari N .  Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients. .  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy27 ( 11 ) 1669 - 1673   2021年11月国際誌

Shohei Yamamoto, Kenji Maeda, Kouki Matsuda, Akihito Tanaka, Kumi Horii, Kaori Okudera, Junko S. Takeuchi, Tetsuya Mizoue, Maki Konishi, Mitsuru Ozeki, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari .  COVID-19 breakthrough infections and pre-infection neutralizing antibody .      2021年10月

Nomoto H, Yamamoto K, Yamada G, Suzuki M, Kinoshita N, Takasaki J, Moriya A, Maeda K, Kimura M, Ohmagari N .  Time-series evaluation of the quantitative antigen test for coronavirus disease 2019: the potential usefulness in infectivity assessment. .  Journal of Infection and Chemotherapy   2021年9月査読

Yasuhiro HayashiKiyoto TsuchiyaMizuki YamamotoYoko Nemoto-SasakiKazunari TanigawaKotaro, HamaYusuke UedaTakashi TanikawaJin GohdaKenji MaedaJun-ichiro, InoueAtsushi Yamashita .  N-(4-Hydroxyphenyl) Retinamide Suppresses SARS-CoV-2 Spike Protein-Mediated Cell-Cell Fusion by a Dihydroceramide Δ4-Desaturase 1-Independent Mechanism .  Journal of Virology95 ( 17 ) e0080721   2021年8月査読 国際誌

Yamamoto Kei, Nagashima Mami, Yoshida Isao, Sadamasu Kenji, Kurokawa Masami, Nagashima Maki, Kinoshita Noriko, Maeda Kenji, Takasaki Jin, Teruya Katsuji, Ohmagari Norio .  新型コロナウイルス(SARS-CoV-2)抗原迅速検査の結果はウイルス培養の結果と相関するか(Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result?) .  Journal of Infection and Chemotherapy27 ( 8 ) 1273 - 1275   2021年8月

Yamamoto S, Tanaka A, Oshiro Y, Ishii M, Ishiwari H, Konishi M, Matsuda K, Ozeki M, Miyo K, Maeda K, Mizoue T, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N .  Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan. .  The Journal of infection83 ( 2 ) 237 - 279   2021年8月査読 国際誌

Yamamoto K, Nagashima M, Yoshida I, Sadamasu K, Kurokawa M, Nagashima M, Kinoshita N, Maeda K, Takasaki J, Teruya K, Ohmagari N .  Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result? .  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy27 ( 8 ) 1273 - 1275   2021年8月査読 国際誌

Yamamoto K, Suzuki M, Yamada G, Sudo T, Nomoto H, Kinoshita N, Nakamura K, Tsujimoto Y, Kusaba Y, Morita C, Moriya A, Maeda K, Yagi S, Kimura M, Ohmagari N .  Corrigendum to "Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission" [Int J Infect Dis 104 (2021) 65-72]. .  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases109   323 - 323   2021年8月国際誌

Maeda K, Amano M, Uemura Y, Tsuchiya K, Matsushima T, Noda K, Shimizu Y, Fujiwara A, Takamatsu Y, Ichikawa Y, Nishimura H, Kinoshita M, Matsumoto S, Gatanaga H, Yoshimura K, Oka SI, Mikami A, Sugiura W, Sato T, Yoshida T, Shimada S, Mitsuya H .  Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals. .  medRxiv : the preprint server for health sciences11 ( 1 ) 22848 - 22848   2021年7月査読 国際誌

Nakajima S, Watashi K, Kato T, Muramatsu M, Wakita T, Tamura N, Hattori SI, Maeda K, Mitsuya H, Yasutake Y, Toyoda T .  Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V Mutations. .  Journal of virology95 ( 16 ) e0240120   2021年7月査読 国際誌

Imai M, Halfmann PJ, Yamayoshi S, Iwatsuki-Horimoto K, Chiba S, Watanabe T, Nakajima N, Ito M, Kuroda M, Kiso M, Maemura T, Takahashi K, Loeber S, Hatta M, Koga M, Nagai H, Yamamoto S, Saito M, Adachi E, Akasaka O, Nakamura M, Nakachi I, Ogura T, Baba R, Fujita K, Ochi J, Mitamura K, Kato H, Nakajima H, Yagi K, Hattori SI, Maeda K, Suzuki T, Miyazato Y, Valdez R, Gherasim C, Furusawa Y, Okuda M, Ujie M, Lopes TJS, Yasuhara A, Ueki H, Sakai-Tagawa Y, Eisfeld AJ, Baczenas JJ, Baker DA, O'Connor SL, O'Connor DH, Fukushi S, Fujimoto T, Kuroda Y, Gordon A, Maeda K, Ohmagari N, Sugaya N, Yotsuyanagi H, Mitsuya H, Suzuki T, Kawaoka Y .  Characterization of a new SARS-CoV-2 variant that emerged in Brazil. .  Proceedings of the National Academy of Sciences of the United States of America118 ( 27 ) e2106535118 - e2106535118   2021年7月査読 国際誌

Inada Makoto, Ishikane Masahiro, Terada Mari, Matsunaga Akihiro, Maeda Kenji, Tsuchiya Kiyoto, Miura Kenji, Sairenji Yu, Kinoshita Noriko, Ujiie Mugen, Kutsuna Satoshi, Ishizaka Yukihito, Mitsuya Hiroaki, Ohmagari Norio .  日本人男性における中和抗体の中和活性(IC50)上昇による無症候性COVID-19再感染(Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration(IC50) of neutralizing antibodies) .  Journal of Infection and Chemotherapy27 ( 7 ) 1063 - 1067   2021年7月

Terada M, Kutsuna S, Togano T, Saito S, Kinoshita N, Shimanishi Y, Suzuki T, Miyazato Y, Inada M, Nakamoto T, Nomoto H, Ide S, Sato M, Maeda K, Matsunaga A, Satake M, Matsubayashi K, Tsuno H, Kojima M, Kuramistu M, Tezuka K, Ikebe E, Okuma K, Hamaguchi I, Shiratori K, Sato M, Kawakami Y, Inaba K, Igarashi S, Yamauchi R, Matsumura M, Ishimaru K, Zhang B, Kuge C, Ishihara M, Gouda M, Tanaka K, Ishizaka Y, Ohmagari N .  How we secured a COVID-19 convalescent plasma procurement scheme in Japan. .  Transfusion61 ( 7 ) 1998 - 2007   2021年7月査読 国際誌

Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N .  Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC₅₀) of neutralizing antibodies. .  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy27 ( 7 ) 1063 - 1067   2021年7月査読 国際誌

Kutsuna Satoshi, Asai Yusuke, Matsunaga Akihiro, Kinoshita Noriko, Terada Mari, Miyazato Yusuke, Nakamoto Takato, Suzuki Tetsuya, Saito Sho, Endo Mio, Kanda Kohei, Maeda Kenji, Takasaki Jin, Hojo Masayuki, Ishizaka Yukihito, Ohmagari Norio .  COVID-19の回復期にある患者における抗SARS-CoV-2 IgG抗体産生の関連因子(Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19) .  Journal of Infection and Chemotherapy27 ( 6 ) 808 - 813   2021年6月

Yamamoto S, Tanaka A, Kobayashi S, Oshiro Y, Ozeki M, Maeda K, Matsuda K, Miyo K, Mizoue T, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N .  Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, Japan. .  Global health & medicine3 ( 2 ) 90 - 94   2021年4月査読

Tanaka A, Yamamoto S, Miyo K, Mizoue T, Maeda K, Sugiura W, Mitsuya H, Sugiyama H, Norio Ohmagari .  Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan .  Journal of Infection82 ( 4 ) e1 - e3   2021年4月査読 国際誌

Yamamoto Shohei, Tanaka Akihito, Kobayashi Shinji, Oshiro Yusuke, Ozeki Mitsuru, Maeda Kenji, Matsuda Kouki, Miyo Kengo, Mizoue Tetsuya, Sugiura Wataru, Mitsuya Hiroaki, Sugiyama Haruhito, Ohmagari Norio .  東京の大規模国立病院の医療従事者におけるSARS-CoV-2に対する迅速血清検査の結果の一貫性(Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, Japan) .  Global Health & Medicine3 ( 2 ) 90 - 94   2021年4月

Maeda K, Higashi-Kuwata N, Kinoshita N, Kutsuna S, Tsuchiya K, Hattori SI, Matsuda K, Takamatsu Y, Gatanaga H, Oka S, Sugiyama H, Ohmagari N, Mitsuya H .  Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma. .  Scientific reports11 ( 1 ) 5563 - 5563   2021年3月査読 国際誌

Noda K, Matsuda K, Yagishita S, Maeda K, Akiyama Y, Terada-Hirashima J, Matsushita H, Iwata S, Yamashita K, Atarashi Y, Watanabe S, Ide N, Yoshida T, Ohmagari N, Mitsuya H, Hamada A .  A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies. .  Scientific reports11 ( 1 ) 5198 - 5198   2021年3月査読 国際誌

Yamamoto K, Suzuki M, Yamada G, Sudo T, Nomoto H, Kinoshita N, Nakamura K, Tsujimoto Y, Kusaba Y, Morita C, Moriya A, Maeda K, Yagi S, Kimura M, Ohmagari N .  Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission. .  Int. J. Infect. Dis.104   65 - 72   2021年査読 国際誌

Kutsuna S, Asai Y, Matsunaga A, Kinoshita N, Terada M, Miyazato Y, Nakamoto T, Suzuki T, Saito S, Endo M, Kanda K, Maeda K, Takasaki J, Hojo M, shizaka Y, Ohmagari N .  Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. .  Journal of Infection and Chemotherapy27 ( 6 ) 808 - 813   2021年査読 国際誌

Yamayoshi S, Yasuhara A, Ito M, Akasaka O, Nakamura M, Nakachi I, Koga M, Mitamura K, Yagi K, Maeda K, Kato H, Nojima M, Pattinson D, Ogura T, Baba R, Fujita K, Nagai H, Yamamoto S, Saito M, Adachi E, Ochi J, Hattori SI, Suzuki T, Miyazato Y, Chiba S, Okuda M, Murakami J, Hamabata T, Iwatsuki-Horimoto K, Nakajima H, Mitsuya H, Omagari N, Sugaya N, Yotsuyanagi H, Kawaoka Y .  Antibody titers against SARS-CoV-2 decline, but do not disappear for several months. .  EClinialMedicine32   100734 - 100734   2021年査読 国際誌

Matsuda K, Kobayakawa T, Kariya R, Tsuchiya K, Ryu S, Tsuji K, Ishii T, Gatanaga H, Yoshimura K, Okada S, Hamada A, Mitsuya H, Tamamura H, Maeda K .  A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC Activators. .  Frontiers in microbiology12   636276 - 636276   2021年査読 国際誌

前田 賢次 .  抗ウイルス感染症研究のフロンティア-ウイルス感染症克服に向けた薬学専門分野での挑戦-　ウイルス関連分子標的アプローチによる抗ウイルス薬の創製　HIV-1からSARS-CoV-2まで .  日本薬学会年会要旨集  2022年3月  (公社)日本薬学会

松田 幸樹, 前田 賢次 .  HIV潜伏感染細胞に対する新規治療法開発に向けた研究 .  Cytometry Research  2021年6月  (一社)日本サイトメトリー学会

石井 貴大, 小早川 拓也, 松田 幸樹, 辻 耕平, 吉村 和久, 満屋 裕明, 前田 賢次, 玉村 啓和 .  HIV感染症の根治を指向したDAG-ラクトン誘導体の合成 .  日本薬学会年会要旨集  2022年3月  (公社)日本薬学会

石井 貴大, 小早川 拓也, 松田 幸樹, 辻 耕平, 吉村 和久, 満屋 裕明, 前田 賢次, 玉村 啓和 .  HIV感染症の根治へ向けたDAG-ラクトン誘導体の構造活性相関研究 .  日本薬学会年会要旨集  2021年3月  (公社)日本薬学会

北村 春樹, 松田 幸樹, 助川 明香, 高橋 一帆, 小早川 拓也, 玉村 啓和, 山岡 昇司, 前田 賢次, 武内 寛明 .  HIV-1潜伏感染細胞排除戦略に有用な新規低分子化合物や既存医薬品の探索および評価 .  日本エイズ学会誌  2021年11月  (一社)日本エイズ学会

野生型と薬剤耐性B型肝炎ウイルスに強力な活性を発揮する新規治療薬の研究・開発

2017年4月 - 2022年3月

国立研究開発法人日本医療研究開発機構 (AMED)  肝炎等克服実用化研究事業 B型肝炎創薬実用化等研究事業